The Annals New | Pharmaco Epidemiology and Therapeutic Risk Management
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     

The Annals of Pharmacotherapy: Vol. 30, No. 1, pp. 55-61.
© 1996 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alderman, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alderman, C.

Research Articles

Adverse effects of the angiotensin-converting enzyme inhibitors

CP Alderman

OBJECTIVE: To review current literature relating to the adverse effects of the angiotensin-converting enzyme (ACE) inhibitors. DATA SOURCES: Online drug information sources, including MEDLINE (1966-November 1994), Iowa Drug Information Service, and the Australian Medical Index (AMI), were used to identify relevant literature, including reviews. DATA EXTRACTION: Data were extracted from studies described in the English-language literature dealing with the adverse effects of ACE inhibitors. Comprehensive reviews and relevant case reports also were included. DATA SYNTHESIS: Important adverse effects of ACE inhibitors include first-dose hypotension, renal dysfunction, hyperkalemia, and cough. Less common adverse effects include angioedema, hepatotoxicity. Skin rashes, and dysgeusia. ACE inhibitors also are associated with adverse fetal effects; thus, this class of drugs in contraindicated in pregnancy. Some adverse effects of ACE inhibitors are predictable on the basis of the fundamental pharmacology of this class of drugs. However, other effects are idiosyncratic in nature, although these reactions are generally much less common. CONCLUSIONS: Attention to the principles of risk assessment, risk immunization, and patient monitoring are important when ACE inhibitor therapy is used for any indication. Provided these steps are taken. ACE inhibitors are generally a safe and effective class of drugs.


This article has been cited by other articles:


Home page
 Hum Exp ToxicolHome page
M. B. Forrester
Adult lisinopril ingestions reported to Texas poison control centers, 1998 2005
Human and Experimental Toxicology, June 1, 2007; 26(6): 483 - 489.
[Abstract] [PDF]

Home page
 Hum Exp ToxicolHome page
M.B. Forrester
Pediatric lisinopril ingestions reported to Texas poison control centers
Human and Experimental Toxicology, February 1, 2007; 26(2): 83 - 89.
[Abstract] [PDF]

Home page
 J. Am. Coll. Nutr.Home page
K. Aihara, O. Kajimoto, H. Hirata, R. Takahashi, and Y. Nakamura
Effect of Powdered Fermented Milk with Lactobacillus helveticus on Subjects with High-Normal Blood Pressure or Mild Hypertension
J. Am. Coll. Nutr., August 1, 2005; 24(4): 257 - 265.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
J K Aronson and R E Ferner
Joining the DoTS: new approach to classifying adverse drug reactions
BMJ, November 22, 2003; 327(7425): 1222 - 1225.
[Full Text] [PDF]

Home page
 Arch Intern MedHome page
G. L. Bakris and M. R. Weir
Angiotensin-Converting Enzyme Inhibitor-Associated Elevations in Serum Creatinine: Is This a Cause for Concern?
Arch Intern Med, March 13, 2000; 160(5): 685 - 693.
[Abstract] [Full Text] [PDF]

Home page
 SEMIN CARDIOTHORAC VASC ANESTHHome page
M. Pfaffendorf
Angiotensin-Converting Enzyme Inhibitors an Angiotensin II-Receptor Antagonists
Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 1998; 2(3): 222 - 230.
[Abstract] [PDF]


homecopy help contact us subscription past issues search current issue
Copyright © 1996 by Harvey Whitney Books Company.